...
首页> 外文期刊>Clinical and Experimental Metastasis >In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice
【24h】

In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice

机译:通过shRNA靶向MACC1在异种移植小鼠体内对结肠直肠癌生长和转移的体内成像

获取原文

摘要

We previously identified the gene metastasis-associated in colon cancer-1 (MACC1) and demonstrated its important role for metastasis prediction in colorectal cancer. MACC1 induces cell motility and proliferation in vitro as well as metastasis in several mouse models. Here we report non-invasive real time imaging of inhibition of colorectal tumor progression and metastasis in xenografted mice by MACC1 shRNA. First, we demonstrated reduction of tumors and liver metastases by endpoint imaging of mice transplanted with MACC1 endogenously high expressing colorectal cancer cells and treated with shRNAs acting on MACC1 or Met. Next, we generated a novel bicistronic IRES vector simultaneously expressing the reporter gene firefly luciferase and MACC1 to ensure a direct correlation of bioluminescence signal with MACC1 expression. We transfected MACC1 endogenously low expressing colorectal cancer cells with this luciferase-IRES-MACC1 construct, transplanted them intrasplenically, and monitored MACC1 induced tumor growth and metastasis by in vivo imaging over time. Transfection of an IRES construct harboring the firefly luciferase reporter gene together with MACC1 lacking the SH3-domain reduced tumor growth and metastasis. Finally, we counteracted the luciferase-IRES-MACC1 induced effects by shRNA targeting MACC1 and monitored reduced tumor growth and metastasis by in vivo imaging over weeks. In summary, the new bicistronic luciferase-IRES-MACC1 construct is suitable for in vivo imaging of tumor progression and metastasis, and moreover, for imaging of therapy response such as treatment with MACC1 shRNA. Thereby, we provide proof-of-concept for employment of this MACC1-based in vivo model for evaluating therapeutic intervention strategies aiming at inhibition of tumor growth and metastasis.
机译:我们先前确定了结肠癌1(MACC1)中与转移相关的基因,并证明了其在结直肠癌转移预测中的重要作用。 MACC1在几种小鼠模型中均可诱导体外细胞运动和增殖以及转移。在这里,我们报告通过MACC1 shRNA抑制异种移植小鼠大肠肿瘤进展和转移的无创实时成像。首先,我们通过对小鼠内源性高表达结直肠癌细胞MACC1移植并用作用于MACC1或Met的shRNA进行治疗的小鼠的终点影像学证实了肿瘤和肝转移的减少。接下来,我们生成了新型双顺反子IRES载体,该载体同时表达了报道基因萤火虫荧光素酶和MACC1,以确保生物发光信号与MACC1表达直接相关。我们用这种荧光素酶-IRES-MACC1构建体转染了内源性低表达的MACC1大肠癌细胞,将其脾内移植,并通过体内成像监测了MACC1诱导的肿瘤生长和转移。带有萤火虫荧光素酶报道基因的IRES构建体和缺少SH3结构域的MACC1的转染减少了肿瘤的生长和转移。最后,我们通过靶向MACC1的shRNA抵消了萤光素酶-IRES-MACC1诱导的效应,并通过数周的体内成像监测了降低的肿瘤生长和转移。总之,新的双顺反子荧光素酶-IRES-MACC1构建体适用于体内肿瘤进展和转移的成像,并且还适用于成像治疗反应,例如用MACC1 shRNA治疗。因此,我们提供了使用基于MACC1的体内模型以评估旨在抑制肿瘤生长和转移的治疗干预策略的概念验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号